advertisement

---

Sit AJ 5

Showing records 1 to 5 | Display all abstracts from Sit AJ

104853 Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Shah SM
American Journal of Ophthalmology 2022; 243: 98-108

---

104841 Emerging drugs for the treatment of glaucoma: a review of phase II & III trials
Kaplan TM
Expert Opinion on Emerging Drugs 2022; 0: 1-11

---

104853 Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Boopathiraj N
American Journal of Ophthalmology 2022; 243: 98-108

---

104841 Emerging drugs for the treatment of glaucoma: a review of phase II & III trials
Sit AJ
Expert Opinion on Emerging Drugs 2022; 0: 1-11

---

104853 Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Starr MR; Starr MR; Dalvin LA; AbouChehade J; Damento G; Garcia MD; Hodge DO; Bakri SJ; Sit AJ; Iezzi R
American Journal of Ophthalmology 2022; 243: 98-108

---